AR015164A1 - Nuevas 1-aril-3-heteroaril-tioureas sustituidas y 1-aril-3-heteroaril-isotioureas sustituidas como agentes antiateroscleroticos, su uso en la manufacturade un medicamento y composicion farmaceutica que las contiene - Google Patents

Nuevas 1-aril-3-heteroaril-tioureas sustituidas y 1-aril-3-heteroaril-isotioureas sustituidas como agentes antiateroscleroticos, su uso en la manufacturade un medicamento y composicion farmaceutica que las contiene

Info

Publication number
AR015164A1
AR015164A1 ARP980104386A ARP980104386A AR015164A1 AR 015164 A1 AR015164 A1 AR 015164A1 AR P980104386 A ARP980104386 A AR P980104386A AR P980104386 A ARP980104386 A AR P980104386A AR 015164 A1 AR015164 A1 AR 015164A1
Authority
AR
Argentina
Prior art keywords
heteroaril
aril
replaced
lower alkyl
pharmaceutical composition
Prior art date
Application number
ARP980104386A
Other languages
English (en)
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR015164A1 publication Critical patent/AR015164A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980104386A 1997-09-03 1998-09-02 Nuevas 1-aril-3-heteroaril-tioureas sustituidas y 1-aril-3-heteroaril-isotioureas sustituidas como agentes antiateroscleroticos, su uso en la manufacturade un medicamento y composicion farmaceutica que las contiene AR015164A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92229997A 1997-09-03 1997-09-03

Publications (1)

Publication Number Publication Date
AR015164A1 true AR015164A1 (es) 2001-04-18

Family

ID=25446856

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104386A AR015164A1 (es) 1997-09-03 1998-09-02 Nuevas 1-aril-3-heteroaril-tioureas sustituidas y 1-aril-3-heteroaril-isotioureas sustituidas como agentes antiateroscleroticos, su uso en la manufacturade un medicamento y composicion farmaceutica que las contiene

Country Status (5)

Country Link
AR (1) AR015164A1 (fr)
AU (1) AU8924098A (fr)
TW (1) TW415942B (fr)
WO (1) WO1999011638A1 (fr)
ZA (1) ZA987973B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101116627B1 (ko) 2002-06-27 2012-10-09 노보 노르디스크 에이/에스 치료제로서 아릴 카르보닐 유도체

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2712630A1 (de) * 1977-03-23 1978-09-28 Bayer Ag 1,3,4-thiadiazol-2-yl-harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas
IL67417A (en) * 1982-01-26 1989-10-31 American Cyanamid Co Antiatherosclerotic substituted ureas,process for their preparation and pharmaceutical compositions containing them
JPH049375A (ja) * 1990-04-25 1992-01-14 Takeda Chem Ind Ltd チオ尿素誘導体及びａｇｅ生成阻害剤
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
US5185358A (en) * 1991-06-24 1993-02-09 Warner-Lambert Co. 3-heteroatom containing urea and thiourea ACAT inhibitors
HUT62558A (en) * 1991-07-01 1993-05-28 Sandoz Ag Process for producing n-phenylthiourea derivaties and pharmaceutical compositions comprising same
NZ250916A (en) * 1993-02-27 1995-08-28 Nihon Nohyaku Co Ltd N-heteroaryl-n'-phenylureas, their use as acat inhibitors
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
DE4438021A1 (de) * 1994-10-25 1996-05-02 Thomae Gmbh Dr K Neue Phenylharnstoffe, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JPH08301841A (ja) * 1995-05-10 1996-11-19 Green Cross Corp:The スクアレン・エポキシダーゼ活性阻害剤
WO1997019932A1 (fr) * 1995-11-28 1997-06-05 American Home Products Corporation Derives 2-thioxo-imidazolin-4-one et leur utilisation pour augmenter la cholesterolemie a lipoproteine de haute densite

Also Published As

Publication number Publication date
WO1999011638A1 (fr) 1999-03-11
AU8924098A (en) 1999-03-22
TW415942B (en) 2000-12-21
ZA987973B (en) 2000-03-22

Similar Documents

Publication Publication Date Title
ES2044878T3 (es) Un proceso para la preparacion de derivados de benzimidazol.
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
ATE249213T1 (de) Pentafluorobenzensulfonamiden und analoge
PE20001485A1 (es) Derivados de la camptotecina que tienen actividad antitumoral
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
DE69533174D1 (de) Pyridopyrimidinone, chinoline und anellierte n-heterozyklen als bradykinin-antagonisten
ES2037752T3 (es) Utilizacion de un derivado de benzoxazol y su procedimiento de preparacion.
ES2033272T3 (es) Acidos silicicos de precipitacion, procedimiento para su preparacion y empleo.
YU49443B (sh) Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
TR199701647A2 (xx) �kame edilmi� purin t�revleri,bunlar�n imalat usul�
DK0738269T3 (da) Piperidinderivater med PAF-antagonistaktivitet
ID25856A (id) Senyawa-senyawa baru
NO20020282D0 (no) Nytt difenylpiperidinderivat
EA200500882A1 (ru) N-арилсульфонил-3-аминоалкоксииндолы
ES2032570T3 (es) Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe).
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
SE9702563D0 (sv) Compounds
EP0337136A3 (fr) Dérivés du pipéridine dans le traitement des effets secondaires de la thérapie neuroleptique